Etoricoxib 60 mg

DRUG7 trials

Conditions

Arthritis, RheumatoidAxial SpondyloarthritisBiomarkers for Prediction of OA Treatment EfficacyCervical OsteoarthritisEffect of DrugKnee, Osteoarthritis (OA)Osteoarthritis, HipPain

Early Phase 1

Comparison of the Anti-Inflammatory Efficacy of Preemptive Dexamethasone and Etoricoxib

NCT05142098

Dow University of Health SciencesEffect of Drug

Start: 2022-01-01End: 2022-08-01Target: 170Updated: 2021-12-16

Phase 2

Modulation of the Surgical Inflammatory Response by Etoricoxib

TerminatedNCT00746720

University of Erlangen-Nürnberg Medical SchoolOsteoarthritis, Hip, Pain, Postoperative Pain

Start: 2006-05-31End: 2010-12-31Updated: 2020-12-14

Phase 3

Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder

TerminatedNCT00876317

Clinica Virgen MilagrosaSoft Tissue Injuries of the Shoulder, Tenosynovitis and Bursitis Affecting the Shoulder

Start: 2009-11-30End: 2010-12-31Updated: 2012-07-03

A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)

CompletedNCT01208181

Organon and CoArthritis, Rheumatoid

Start: 2010-09-27End: 2014-07-29Updated: 2024-06-18

Phase 4

Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients

CompletedNCT03582332

Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshAxial Spondyloarthritis

Start: 2016-01-02End: 2016-06-23Updated: 2018-07-11

Unknown Phase

Pulse Shortwave Therapy in Cervical Osteoarthritis

CompletedNCT03542955

BioElectronics CorporationCervical Osteoarthritis

Start: 2018-05-01End: 2019-07-30Updated: 2019-08-30

Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

CompletedNCT05256342

Rambam Health Care CampusBiomarkers for Prediction of OA Treatment Efficacy, Knee, Osteoarthritis (OA)

Start: 2021-12-30End: 2024-04-08Updated: 2024-04-12

Related Papers

Pulsed Shortwave Therapy in Cervical Osteoarthritis: an NSAID- Controlled, Randomized Clinical Trial

SN Comprehensive Clinical Medicine2021-01-013 citations

Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial

BMC Musculoskeletal Disorders2016-08-0825 citations